Immunotherapy Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Immunotherapy Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunotherapy
New immunotherapy research from Medical School, Department of Medicine discussed
April 11th, 2007
Data detailed in "Recent advances in immunotherapy for hepatocellular cancer" have been presented. According to recent research from the United States, "There is a continuing need for innovative, alternative therapies for hepatocellular carcinoma (HCC). Immunotherapy of cancer is attractive because of the exquisite specificity of the immune response." "Activation of an HCC-specific response can be accomplished by strategies targeting tumour-associated antigens (for example: alpha fetoprotein (AFP)) or viral antigens in those patients infected with hepatitis B or C. Uncharacterised and mutated antigens can also be targeted with whole tumor cell or tumor lysate-based...
Source: Immunotherapy Weekly (2007-04-11)
|
